# Apollo Hospitals Enterprise Ltd (APOLLOHOSP)
> Exchange: NSE | Sector: Pharma | ISIN: INE437A01024

## Price
Current Price: ₹8308.5
Day Change: +2.85%
52W High: ₹8249.95
52W Low: ₹6680
Market Cap: ₹1,16,201 Cr

## Valuation
P/E: 64.52
P/B: 12.78
EPS: ₹125.26
Book Value: ₹632.45
Dividend Yield: 0.25%

## Returns
1Y Return: 7.74%

## Profitability
ROE: 0%
ROCE: 25.7%
Debt/Equity: 0.84
Revenue Growth: 17.2%
Profit Growth: 35%
EBITDA Margin: 13.27%
Operating Margin: 11.52%

## About
Apollo Hospitals is a leading Indian company in the Pharmaceuticals space, listed on the NSE. The company is a key player in the Pharma — Formulations segment with a strong market position and diversified operations.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Pharma — Formulations

## Business Model
Overview: Apollo Hospitals Enterprise Ltd makes money through Core Business, Other Segments, Exports in Pharma — Formulations. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Core Business
- Other Segments
- Exports
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Business Segments:
- Core Business: 73% of tracked revenue, equal to ₹25,566 Cr. | 73% | ₹25,566 Cr
- Other Segments: 29% of tracked revenue, equal to ₹10,156 Cr. | 29% | ₹10,156 Cr
- Exports: -2% of tracked revenue, equal to ₹-700 Cr. | -2% | ₹-700 Cr
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Announcement: Outcome Of The Board Meeting - Update
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:00.503Z
Price History Updated: 2026-05-17T21:29:38.028Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:29:38.028Z
Quant Updated: 2026-05-17T21:29:38.028Z
Sentiment Updated: 2026-05-17T21:29:38.028Z
Financials Status: current
Financials Updated: 2026-05-18T02:34:12.592Z
Financials Last Attempt: 2026-05-18T02:34:12.592Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹4357 Cr
Operating Profit: ₹676 Cr (OPM 16%)
Net Profit: ₹315 Cr
Tax: ₹407 Cr

## Annual P&L History
Mar 2015: Rev ₹4357Cr | PAT ₹315Cr | OPM 16%
Mar 2016: Rev ₹5129Cr | PAT ₹335Cr | OPM 14%
Mar 2017: Rev ₹6150Cr | PAT ₹235Cr | OPM 11%

## Balance Sheet (Mar 2015)
Total Assets: ₹5350 Cr
Total Liabilities: ₹5350 Cr
Borrowings: ₹1344 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Prathap Chandra Reddy FCCP, FICA, FRCS, M.D., MBBS, Founder & Executive Chairman
- Suneeta  Reddy, Joint MD & Executive Director
- Konda Sangita Reddy M.D., Joint MD & Executive Director
- P. Preetha Reddy B.Sc., M.D., Executive Vice-Chairperson
- Krishnan  Akhileswaran, Chief Financial Officer

## Highlights
- Strong revenue growth of 11% CAGR over 5 years
- ROE of 15.0% indicates efficient capital allocation

## Concerns
- Debt-to-equity ratio needs monitoring amid expansion plans
- Promoter holding has seen slight decline in recent quarters

---
Source: rupiya.io/stocks/apollohosp
Disclaimer: For research and education only. Not investment advice.